Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Ocugen (OCGN) over the last 7 years, with Q3 2025 value amounting to 1141.84%.

  • Ocugen's EBITDA Margin rose 3300.0% to 1141.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1191.53%, marking a year-over-year decrease of 1032700.0%. This contributed to the annual value of 1332.33% for FY2024, which is 2872000.0% down from last year.
  • Per Ocugen's latest filing, its EBITDA Margin stood at 1141.84% for Q3 2025, which was up 3300.0% from 1075.53% recorded in Q2 2025.
  • In the past 5 years, Ocugen's EBITDA Margin ranged from a high of 35385.0% in Q1 2021 and a low of 5127.25% during Q3 2022
  • Over the past 5 years, Ocugen's median EBITDA Margin value was 1257.18% (recorded in 2024), while the average stood at 129.98%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 90916700bps in 2021, then crashed by -391880000bps in 2022.
  • Quarter analysis of 5 years shows Ocugen's EBITDA Margin stood at 35385.0% in 2021, then tumbled by -107bps to 2548.12% in 2022, then skyrocketed by 69bps to 779.06% in 2023, then crashed by -133bps to 1813.48% in 2024, then soared by 37bps to 1141.84% in 2025.
  • Its EBITDA Margin was 1141.84% in Q3 2025, compared to 1075.53% in Q2 2025 and 1037.0% in Q1 2025.